These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26608264)

  • 1. [Biomarkers for chronic inflammatory diseases].
    Holzinger D; Föll D
    Z Rheumatol; 2015 Dec; 74(10):887-96; quiz 897. PubMed ID: 26608264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
    Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
    J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel immunodiagnostics for inflammatory arthritis].
    Wahle M; Kling E
    Z Rheumatol; 2016 May; 75(4):361-6. PubMed ID: 27142378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis.
    Brunner J; Sitzmann FC
    Clin Exp Rheumatol; 2006; 24(4):449-51. PubMed ID: 16956438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D; Gülmez D; Hasçelik G
    Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
    Moore TL; Gillian BE; Crespo-Pagnussat S; Feller L; Chauhan AK
    Clin Exp Rheumatol; 2014; 32(5):740-6. PubMed ID: 25068682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of biomarkers in diagnostics and forecasting of effectiveness of modern therapy of rheumatoid arthritis].
    Aleksandrova EN; Novikov AA; Nasonov EL
    Klin Lab Diagn; 2013 Aug; (8):3-13. PubMed ID: 24340741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: a comparative study.
    Gilliam BE; Chauhan AK; Low JM; Moore TL
    Clin Exp Rheumatol; 2008; 26(3):492-7. PubMed ID: 18578976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
    Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
    Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum calprotectin: review of its usefulness and validity in paediatric rheumatic diseases.
    Mariani A; Marsili M; Nozzi M; Faricelli R; Chiarelli F; Breda L
    Clin Exp Rheumatol; 2015; 33(1):109-14. PubMed ID: 25535818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis.
    Hammer HB; Ødegård S; Syversen SW; Landewé R; van der Heijde D; Uhlig T; Mowinckel P; Kvien TK
    Ann Rheum Dis; 2010 Jan; 69(1):150-4. PubMed ID: 19095696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic laboratory markers of joint damage in rheumatoid arthritis.
    Lindqvist E; Eberhardt K; Bendtzen K; Heinegård D; Saxne T
    Ann Rheum Dis; 2005 Feb; 64(2):196-201. PubMed ID: 15458956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis.
    Lee DM; Phillips R; Hagan EM; Chibnik LB; Costenbader KH; Schur PH
    Ann Rheum Dis; 2009 Feb; 68(2):201-8. PubMed ID: 18390910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of Anti-cyclic Citrullinated Peptide Autoantibodies in Immune-mediated Inflammatory Skin Disorders with and without Arthritis.
    Grover C; Kashyap B; Daulatabad D; Dhawan A; Kaur IR
    Indian J Dermatol; 2016; 61(5):510-4. PubMed ID: 27688439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
    Habib HM; Mosaad YM; Youssef HM
    Immunol Invest; 2008; 37(8):849-57. PubMed ID: 18991100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis.
    Pang SY; Liu HY; Huang YJ; Liu YF; Dai YM; Zeng P; Zeng HS
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide Antibody, C-Reactive Protein, and Erythrocyte Sedimentation Rate for the Clinical Diagnosis of Rheumatoid Arthritis.
    Shen R; Ren X; Jing R; Shen X; Chen J; Ju S; Yang C
    Lab Med; 2015; 46(3):226-9. PubMed ID: 26199263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and predictive value of anti-cyclic citrullinated protein antibodies for future development of rheumatoid arthritis in early undifferentiated arthritis.
    Emad Y; Shehata M; Ragab Y; Saad A; Hamza H; Abou-Zeid A
    Mod Rheumatol; 2010 Aug; 20(4):358-65. PubMed ID: 20364358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study.
    Janssen KM; de Smit MJ; Brouwer E; de Kok FA; Kraan J; Altenburg J; Verheul MK; Trouw LA; van Winkelhoff AJ; Vissink A; Westra J
    Arthritis Res Ther; 2015 Jul; 17(1):174. PubMed ID: 26155788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.